Zydus launches Sitaglynand Siglyn for managing type-II diabetes
Sitaglyn and Siglyn offer an oral solution to the patients providing ease of convenience and better compliance
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
Zydus receives final approval from US FDA for Empagliflozin and Metformin Hydrochloride Tablets
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults…
Zydus receives final approval from US FDA for Lacosamide Injection
Lacosamide Injection is used to treat partial-onset seizures
Zydus Lifesciences receives final approval from US FDA for Adapalene and Benzoyl Peroxide Topical…
A combination of Adapalene (a retinoid) and Benzoyl Peroxide (an antibiotic and skin-peeling agent), the gel is used to decrease…
Zydus Lifesciences receives final approval from US FDA for Famotidine tablets
Famotidine is a histamine H2 receptor blocker
Zydus Lifesciences Q4 profit declines 41 per cent to Rs 397 crores
Consolidated total revenue from operations during the quarter under review stood at Rs 3,863.8 crores as against Rs 3,670.3 crores…
Zydus receives tentative approval from US FDA for Selexipag tablets
Selexipag is used in adults to treat Pulmonary Arterial Hypertension (PAH) to delay disease progression and reduce the risk of…
Zydus receives final approval from US FDA for Bortezomib for injection
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to Covaxin, ZyCov-D and Corbevax
Zydus announces publication of “Dream-ND” and “Dream-D” phase-III trials of Desidustat in “American…
Desidustat’s development is based on the Nobel Prize in Medicine winning science on discoveries of the oxygen-sensing mechanism of…